High-Risk Resectable NSCLC
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB11714 | Durvalumab | 1 | Completed | 1 |
| DB09035 | Nivolumab | 1 | Completed | 1 |
| DB09037 | Pembrolizumab | 1 | Completed | 1 |
| DB15765 | Sintilimab | 1 | Completed | 1 |
| DB14922 | Tislelizumab | 1 | Completed | 1 |
| DB15043 | Toripalimab | 1 | Completed | 1 |